16.3 Critical Limb Ischemia & Acute Arterial Occlusion

Definition & Pathophysiology of Acute Limb Ischemia

Acute Limb Ischemia (ALI) is defined as a sudden, rapid decrease in lower or upper extremity arterial perfusion that threatens the viability of the affected limb, typically presenting within days to less than 2 weeks following symptom onset. ALI must be distinguished from Chronic Limb-Threatening Ischemia (CLTI), which represents the end-stage progression of chronic peripheral artery disease (PAD) evolving over months with chronic ischemic rest pain, non-healing arterial ulcers, or gangrene.

Tissue Vulnerability & The Ischemic Time Window

Tissues within an extremity possess markedly disparate tolerances to warm ischemia:

• Peripheral Nerves (Most Sensitive): Peripheral sensory and motor nerves possess high metabolic demands. Functional neural impairment manifests within 15 to 30 minutes of complete arterial cessation. The loss of light touch, two-point discrimination, and vibratory sensation precedes motor deficits.
• Skeletal Muscle: Skeletal muscle tissue can survive warm ischemia for approximately 4 to 6 hours. Beyond 6 hours of complete ischemia without arterial inflow, irreversible muscle cell membrane disruption, myocyte necrosis, intracellular edema, and fixed muscular contracture (rigor) inevitably develop.
• Skin & Subcutaneous Tissue (Most Resilient): Cutaneous and subcutaneous tissues can survive up to 12 to 24 hours of ischemia due to lower baseline metabolic requirements. Consequently, skin may appear viable even when underlying skeletal muscle compartments have already suffered irreversible necrosis.

---\n

The Classic "6 P's" of Acute Arterial Occlusion

The clinical syndrome of acute arterial occlusion is defined by the cardinal 6 P's, which reflect progressive neurovascular and muscular deprivation:

                         THE 6 P'S OF ACUTE ARTERIAL OCCLUSION
                         
  ┌───────────────┬─────────────────────────────────────────────────────────────┐
  │ 1. PAIN       │ Earliest, most common symptom; severe, agonizing distal ache│
  │               │ Exacerbated by limb elevation; minimally responsive to meds │
  ├───────────────┼─────────────────────────────────────────────────────────────┤
  │ 2. PALLOR     │ Waxy, cadaveric marble-white blanching; delayed refill      │
  │               │ Fixed non-blanching violaceous mottling indicates necrosis  │
  ├───────────────┼─────────────────────────────────────────────────────────────┤
  │ 3. POIKILO-   │ Extremity becomes ice cold, equilibrating with room ambient │
  │    THERMIA    │ temperature; sharp temperature demarcation one level below  │
  ├───────────────┼─────────────────────────────────────────────────────────────┤
  │ 4. PULSELESS- │ Loss of palpable and handheld continuous-wave Doppler pulses│
  │    NESS       │ Compare with contralateral limb; absent signal = occlusion  │
  ├───────────────┼─────────────────────────────────────────────────────────────┤
  │ 5. PARESTHE-  │ Earliest sensitive sign of nerve hypoxia; tingling, numbness│
  │    SIAS       │ Reduced light touch and proprioception; heralds threat      │
  ├───────────────┼─────────────────────────────────────────────────────────────┤
  │ 6. PARALYSIS  │ LATE, OMINOUS SIGN; muscle weakness, foot drop, loss of toe │
  │               │ motion; heralds irreversible necrosis within 4 to 6 hours   │
  └───────────────┴─────────────────────────────────────────────────────────────┘

1. Pain: The earliest and most frequent presenting symptom. Typically abrupt in onset, excruciating, sharp, and localized to the distal extremity (foot, toes, or calf). It is exacerbated by elevation and slightly relieved by hanging the foot in a dependent position. (Note: in advanced Category III ischemia or severe diabetic neuropathy, pain may paradoxically subside due to ischemic death of sensory nerve endings).
2. Pallor: Marked cutaneous blanching. In early ischemia, capillary refill is prolonged ($>3$ to 5 seconds). With prolonged hypoperfusion, stagnant deoxygenated blood in dermal venules produces a mottled, cyanotic appearance. Fixed, non-blanching violaceous mottling (livedo reticularis) signifies microvascular thrombosis and irreversible tissue necrosis.
3. Poikilothermia (Coldness): The limb loses thermoregulatory perfusion and equilibrates with the ambient room temperature, feeling "ice cold." A distinct, palpable line of temperature demarcation can often be appreciated, typically located one anatomic level distal to the point of arterial obstruction (e.g., common femoral artery occlusion causes coldness starting at the mid-to-lower thigh; popliteal artery occlusion produces coldness from the mid-calf down).
4. Pulselessness: Complete absence of palpable peripheral arterial pulses (femoral, popliteal, dorsalis pedis, posterior tibial) distal to the occlusion. Must always be verified and compared with the contralateral asymptomatic limb.
5. Paresthesias: Sensory deficit: tingling, prickling ("pins and needles"), hypoesthesia, and numbness. Sensory nerves are the first to fail under hypoxia; paresthesia is therefore the earliest and most sensitive physical sign of limb-threatening ischemia.
6. Paralysis: Motor deficit: weakness of toe flexion/extension, inability to dorsiflex the ankle (foot drop), and loss of intrinsic foot muscular function. Paralysis is an ominous, late finding signifying profound ischemia of large somatic motor nerve trunks and intrinsic skeletal muscle fibers. It demands emergent revascularization within hours to prevent permanent disability or amputation.

---\n

Etiological Classification: Arterial Embolism vs. In Situ Thrombosis

Identifying the underlying mechanism is essential because the surgical and endovascular management approaches diverge substantially:

---\n

Bedside Diagnostic Evaluation

1. Handheld Continuous-Wave Doppler Ultrasound:
   • Indispensable extension of the physical examination. Evaluates both arterial and venous signals at the dorsalis pedis, posterior tibial, and popliteal levels.
   • Arterial Signal Characteristics: Normal peripheral arteries generate a triphasic waveform (systolic forward flow, early diastolic reversal, late diastolic forward flow) or biphasic waveform. In severe arterial occlusion, flow becomes monophasic (damped, low-resistance) or completely absent (inaudible).
   • Venous Doppler Audibility: Spontaneous, respiratory-phasic venous Doppler sounds confirm patent microvascular return. Inaudible venous flow indicates microvascular thrombosis, stagnant blood column, and advanced, irreversible ischemia.
2. Ankle-Brachial Index (ABI):
   • Calculated by dividing the highest systolic ankle pressure (DP or PT) by the highest brachial systolic pressure. In acute limb ischemia, distal pressures are frequently unmeasurable or yield an ABI $<0.4$, confirming critical hypoperfusion.
3. Urgent Vascular Imaging:
   • Diagnostic imaging must NEVER delay emergency operative revascularization in an immediately threatened limb (Rutherford Category IIb).
   • Computed Tomographic Angiography (CTA) of the lower extremities with runoff: Modality of choice in viable or marginally threatened limbs. Fast, non-invasive, delineates the exact anatomical level of occlusion, status of distal runoff vessels, and presence of collaterals or aneurysms.
   • Catheter Digital Subtraction Angiography (DSA): Gold standard; performed directly in the hybrid operating room or catheterization suite. Combines definitive diagnostic visualization with immediate endovascular intervention (thrombolysis, suction thrombectomy, angioplasty).
4. Laboratory Markers of Muscle Necrosis:
   • Serum Creatine Kinase (CK): Direct quantitative marker of skeletal muscle cellular lysis. Surges with extensive rhabdomyolysis.
   • Serum Potassium & Chemistry Panel: Acute cellular ischemia leaks intracellular potassium; hyperkalemia must be identified and aggressively managed.
   • Urine Myoglobin: Detects myoglobinuria (tea-colored urine, urine dipstick positive for blood with few or no red blood cells on microscopic examination).
   • Serum Lactate: Evaluates systemic lactic acidosis and tissue hypoperfusion.

---\n

The Rutherford Classification of Acute Limb Ischemia

The Society for Vascular Surgery (SVS) Rutherford Clinical Classification stratifies acute limb ischemia into three operational categories that dictate urgency and modality of treatment:

---\n

Emergency Therapeutic Management & Revascularization

1. Immediate Systemic Heparinization

• First-Line Medical Mandate: The very first intervention upon clinical diagnosis of ALI is the immediate administration of intravenous Unfractionated Heparin (UFH).
• Dosing: 80 units/kg IV bolus (maximum 5,000 units), followed by a continuous infusion of 18 units/kg/hour, targeting a therapeutic activated partial thromboplastin time (aPTT 1.5–2.5 times control) or anti-Xa level (0.3–0.7 IU/mL).
• Mechanistic Rationale: Heparin does not dissolve the occluding thrombus; rather, it prevents thrombus propagation both proximally and distally, protects the patency of distal microvascular runoff beds, and prevents secondary thrombosis in stagnant venous beds.

2. Supportive Extremity Management

• Positioning: Keep the affected extremity in a neutral or slightly dependent position (gravity encourages collateral arterial perfusion). NEVER ELEVATE THE LIMB, as elevation drops hydrostatic perfusion pressure and accelerates tissue ischemia.
• Limb Protection: Protect the insensate limb with soft padding (e.g., heel protector boot, cotton wrapping). Avoid thermal trauma: never apply heating pads or ice packs, which cause catastrophic burns in ischemic, numb tissue.
• Hydration: Aggressive intravenous isotonic crystalloid hydration to preserve renal tubular perfusion.

3. Revascularization Modalities

• Surgical Balloon Thromboembolectomy (Fogarty Catheter):
  • Procedure of choice for acute embolic occlusions and immediately threatened limbs (Rutherford Category IIb).
  • Performed under local or general anesthesia. Transverse arteriotomy (typically common femoral artery). A balloon-tipped Fogarty catheter is threaded beyond the occlusion, the balloon is gently inflated with saline, and the catheter is withdrawn, sweeping out the clot.
• Catheter-Directed Thrombolysis (CDT):
  • Local infusion of a fibrinolytic agent (recombinant tissue plasminogen activator, alteplase [tPA]) directly into the thrombus via a multi-sidehole catheter embedded inside the clot. Infusion rate: 0.5 to 1.0 mg/hour of tPA over 12 to 24 hours.
  • Indicated for viable or marginally threatened extremities (Rutherford Category I and IIa) with thrombosed bypass grafts or extensive in situ atherosclerotic thrombosis, where an open surgical approach is technically challenging.
• Percutaneous Mechanical Thrombectomy (PMT):
  • Endovascular rheolytic, rotational, or suction aspiration thrombectomy devices that fragment and aspirate thrombus. Frequently combined with low-dose tPA (pharmacomechanical thrombectomy) to debulk clot rapidly and shorten infusion times.
• Surgical Bypass Grafting / Endarterectomy:
  • Required when balloon embolectomy fails to restore adequate downstream flow, or when severe underlying atherosclerotic occlusive disease precludes simple embolectomy.

---\n

Reperfusion Syndrome & Acute Compartment Syndrome

1. Post-Ischemic Reperfusion Syndrome

Restoring arterial blood flow to severely ischemic skeletal muscle triggers a paradoxical burst of cellular destruction mediated by reactive oxygen species (ROS), calcium overload, endothelial hyperpermeability, and complement activation. The washout of cellular breakdown products into the systemic circulation causes:

• Hyperkalemia: Cellular lysis dumps massive intracellular potassium into the venous system, risking peaked T waves, conduction block, ventricular fibrillation, and sudden asystolic arrest immediately upon surgical arterial un-clamping.
• Rhabdomyolysis & Acute Tubular Necrosis (ATN): Massive myoglobin release precipitates in renal tubules with Tamm-Horsfall mucoprotein, particularly in acidic urine, causing direct tubular cytotoxicity and acute oliguric renal failure.
• Severe Lactic Acidosis: Washout of anaerobic metabolites causes systemic vasodilation and myocardial depression.
• Management: Vigorous IV crystalloid hydration ($100–200$ mL/h) to maintain high urine output ($\ge 100–200$ mL/h), intravenous sodium bicarbonate to alkalinize the urine (target urine pH $>6.5$), continuous cardiac monitoring, and immediate treatment of hyperkalemia (calcium gluconate, insulin/dextrose, potassium binders).

2. Post-Reperfusion Acute Compartment Syndrome

Capillary leak and post-ischemic muscle edema within the rigid, unyielding osteofascial compartments of the leg (most commonly the anterior compartment) cause interstitial pressure to exceed capillary perfusion pressure, obliterating microvascular blood flow.

• Clinical Presentation:
  • Tense, hard, "wooden" swollen muscle compartments;
  • Severe pain out of proportion to exam, exquisitely aggravated by PASSIVE STRETCH of the muscles in the affected compartment (e.g., passive ankle plantarflexion stretches the anterior compartment muscles, triggering severe pain)—the single most sensitive early physical finding;
  • Paresthesias in the distribution of the nerve coursing through that compartment (e.g., deep peroneal nerve compression produces numbness in the first web space between the great and second toes);
  • Exam Pearl: Distal arterial pulses often remain palpable in early-to-moderate compartment syndrome because systolic blood pressure (120 mm Hg) exceeds intracompartmental pressure (35 mm Hg), even though microvascular capillary beds are completely collapsed!
• Intracompartmental Pressure Measurement (Stryker Needle):
  • Absolute intracompartmental pressure $>30$ mm Hg, or a Delta P $\le 30$ mm Hg (defined as $\text{Diastolic Blood Pressure} - \text{Intracompartmental Pressure}$), establishes the diagnosis.
• Definitive Treatment:
  • Emergent Surgical Four-Compartment Fasciotomy.
  • Decompresses all four lower leg compartments (anterior, lateral, superficial posterior, deep posterior) via two long longitudinal incisions (anterolateral and posteromedial).
  • Prophylactic fasciotomy should be performed concurrently during revascularization whenever ischemic time exceeds 4 to 6 hours.